---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-056416"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2023-10-30T23:59:59+00:00"
generated_at: "2026-06-09T06:02:33.867819+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Reneo Pharmaceuticals repurchases 576,443 shares from vTv Therapeutics for $4.4M

## Summary
- Repurchased 576,443 shares at $7.64/share ($4.4M aggregate) from vTv Therapeutics LLC in a private transaction.
- Common Stock Repurchase Agreement dated October 30, 2023, with no further repurchase commitments disclosed.
- Repurchased shares will be retired or held as treasury stock, per standard practice.

## SEC filing metadata
- accession: 0000950170-23-056416
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2023-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000095017023056416/0000950170-23-056416-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000095017023056416/rphm-20231030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-056416
- JSON: https://secwatch.observer/filing/0000950170-23-056416.json
- Plain text: https://secwatch.observer/filing/0000950170-23-056416.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.